Additionally, CD4+ T cells can further promote the antitumor activity of CD8+ T cells by modulating immunosuppressive cells in the tumor microenvironment, such as Tregs and MDSCs (Myeloid-Derived Suppressor Cells) (34). The gene discussed is CD8A; the disease is neoplasm.